The Treatment Action Group (TAG) and AVAC recently released their latest report, Funding Scientific Innovation: Global Investments in HIV Treatment Research and Development in 2010 and 2011. The report, supported by UNAIDS, found US$2.6 billion was invested in HIV treatment research and development (R&D) in 2011.
The investments tracked between 2009 and 2011 demonstrate a steady—albeit small—increase in funding. Inflation and flatlining of public-sector budgets now put HIV treatment discovery in jeopardy, and there is concern that investment will decline further with the impact of sequestration—the automatic across-the-board spending cuts to US government spending that began March 1.
This interactive webinar with funders and advocates around the globe explores the major findings in this report and discusses the implications of possible declining investments in HIV treatment R&D.
A recording has been made available on the TAG website .